SHPG

Allergan to Valeant: Thanks, But No Thanks

moreView todays social media effects on SHPGView the latest stocks trending across Twitter. Click to view dashboardSee who Shire is hiring next, click here to view […]

Valeant Beats on Earnings in Q1

moreView todays social media effects on SHPGView the latest stocks trending across Twitter. Click to view dashboardSee who Shire is hiring next, click here to view […]

Shire Adds to Rare Disease Portfolio with Acquisition of Lumena Pharmaceuticals, Bringing Late Stage Compounds for Rare GI/Hepatic Conditions

[PR Newswire] – Adds to Shire’s rare diseases portfolio and leverages this expertise, and is a perfect combination with Shire’s already strong Gastrointestinal (GI) presence Very attractive opportunity to develop treatments for significant unmet need in moreView todays social media effects on SHPGView the latest stocks trending across Twitter. Click to view dashboardSee who Shire is hiring next, click […]

Corcept Plunges on Study Results

moreView todays social media effects on SHPGView the latest stocks trending across Twitter. Click to view dashboardSee who Shire is hiring next, click here to view […]

SHIRE PLC Files SEC form 10-Q, Quarterly Report

moreView todays social media effects on SHPGView the latest stocks trending across Twitter. Click to view dashboardSee who Shire is hiring next, click here to view […]

U.S. Stock Indexes End Mixed; Apple, Shire Rally

moreView todays social media effects on SHPGView the latest stocks trending across Twitter. Click to view dashboardSee who Shire is hiring next, click here to view […]